SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-089429
Filing Date
2021-07-06
Accepted
2021-07-06 16:20:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2121302d6_sc13d.htm SC 13D 41195
  Complete submission text file 0001104659-21-089429.txt   42668
Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
DELUCCIA ROBERT J (Filed by) CIK: 0001127423 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Subject) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92645 | Film No.: 211074350
SIC: 2834 Pharmaceutical Preparations